National Cancer Institute - Cancer.gov

Search CCR Clinical Trials

Below is a full list of clinical trials conducted by the NCI Center for Cancer Research in Bethesda, Maryland.

  • All trials take place at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.
  • Travel assistance for patients is provided.
  • Trials are available for patients with cancer, HIV, or immunodeficiency disorders.
  • Trials listed below as "Open - Recruiting" are currently enrolling and "Open - Not yet Recruiting" will be enrolling soon.
Open - Not yet Recruiting
Summary Not Yet Available. Call Referral Contact.

Collection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders

Protocol ID
000077
Investigator
Clint T. Allen, M.D.
Open - Recruiting
Summary Not Yet Available. Call Referral Contact.

A PHASE 1B/2 BASKET STUDY OF ACR-368 AS MONOTHERAPY AND IN COMBINATION WITH GEMCITABINE IN ADULT SUBJECTS WITH PLATINUM-RESISTANT OVARIAN CARCINOMA, ENDOMETRIAL ADENOCARCINOMA, AND UROTHELIAL CARCINOMA BASED ON ACRIVON ONCOSIGNATURE® STATUS

Protocol ID
001004
Investigator
Jung-Min Lee, M.D.
Open - Not yet Recruiting
Summary Not Yet Available. Call Referral Contact.

Phase II trial of Stereotactic Body Radiation Therapy followed by IL-15 Superagonist with or without Vaccine in Biochemically Recurrent Prostate Cancer

Protocol ID
IRB001500
Investigator
Ravi A. Madan, M.D.
Open - Not yet Recruiting
Summary Not Yet Available. Call Referral Contact.

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation with JSP191-Based Conditioning in Participants with GATA2 Deficiency

Protocol ID
IRB001531
Investigator
Danielle E. Arnold, M.D.
Open - Not yet Recruiting
Summary Not Yet Available. Call Referral Contact.

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide® ISA-51 VG with Entinostat and Nivolumab as Adjuvant Therapy following Chemoradiation Therapy with or without Surgery for Locally Advanced Esophageal Cancer

Protocol ID
IRB001544
Investigator
David S. Schrump, M.D., M.B.A., FACS
Open - Not yet Recruiting
Summary Not Yet Available. Call Referral Contact.

Expanded Use for a Single Patient Protocol Using Short-Term Cultured, Autologous Tumor Infiltrating Lymphocytes from Patients with Non-Small Cell Lung Cancer Following a Lymphocyte Depleting Chemotherapy Regimen

Protocol ID
IRB001622
Investigator
James C. Yang, M.D.